Natural drug development provides an intellectual property advantage.
Unlike synthetically-derived drugs, botanical drugs are complex mixtures derived from natural sources. This complexity makes them difficult to replicate without knowledge of the exact manufacturing processes. As a result, our drug candidates have excellent protection beyond the patents we have been issued.
While there are many ways to create synthetic drugs, the methods to extract, purify, and standardize naturally-occurring psychedelic compounds are finite and therefore more readily protected with IP.